IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$297M
AUM Growth
-$31.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
70
New
Increased
Reduced
Closed

Top Buys

1
+$11M
2
+$8.45M
3
+$8.21M
4
BIIB icon
Biogen
BIIB
+$7.81M
5
GILD icon
Gilead Sciences
GILD
+$6.85M

Top Sells

1
+$14.3M
2
+$11.8M
3
+$9.48M
4
HRMY icon
Harmony Biosciences
HRMY
+$8.89M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$8.55M

Sector Composition

1 Healthcare 99.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
51
Insmed
INSM
$31.2B
$1.01M 0.34%
40,100
BPMC
52
DELISTED
Blueprint Medicines
BPMC
$1M 0.34%
+20,000
AKRO
53
DELISTED
Akero Therapeutics
AKRO
$935K 0.32%
18,489
-60,000
KZR icon
54
Kezar Life Sciences
KZR
$51.8M
$831K 0.28%
+70,383
NTLA icon
55
Intellia Therapeutics
NTLA
$1.79B
$758K 0.26%
24,000
PRTA icon
56
Prothena Corp
PRTA
$506M
$723K 0.24%
+15,000
AGIO icon
57
Agios Pharmaceuticals
AGIO
$1.71B
$594K 0.2%
24,000
BEAM icon
58
Beam Therapeutics
BEAM
$2.91B
$565K 0.19%
23,500
VTYX icon
59
Ventyx Biosciences
VTYX
$1B
$521K 0.18%
15,000
VIR icon
60
Vir Biotechnology
VIR
$1.3B
$440K 0.15%
+47,000
NBP
61
NovaBridge Biosciences American Depositary Shares
NBP
$398M
$410K 0.14%
310,499
PTCT icon
62
PTC Therapeutics
PTCT
$5.33B
$381K 0.13%
17,000
ARVN icon
63
Arvinas
ARVN
$860M
$334K 0.11%
17,000
PTGX icon
64
Protagonist Therapeutics
PTGX
$5.89B
$332K 0.11%
19,900
RLMD icon
65
Relmada Therapeutics
RLMD
$355M
$30K 0.01%
10,000
APLS icon
66
Apellis Pharmaceuticals
APLS
$2.65B
– –
-129,700
HCM icon
67
HUTCHMED
HCM
$2.39B
– –
-68,000
SAGE
68
DELISTED
Sage Therapeutics
SAGE
– –
-20,000
TVTX icon
69
Travere Therapeutics
TVTX
$2.64B
– –
-441,019
HZNP
70
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-67,000
1 2
3